INTRODUCTION
The peptide elongation cycle is guided by the ribosome and involves sequential selection of aminoacyl-tRNAs, the peptidyl transfer reaction, and subsequent translocation by one codon on the mRNA. These steps are tuned by evolution to obtain an optimal balance between rate and accuracy of peptide synthesis to maximize cell growth rate (Johansson et al., 2012) . At the same time, the rate of peptide synthesis must be tunable both globally (to respond to changing environments) and locally (for regulatory reasons, such as for the formation of protein secondary structures or regulatory rearrangements of mRNA structure). However, the mechanistic underpinnings of translational regulation remain unclear.
The ribosomal nascent peptide exit tunnel (NPET) plays an active role in translational control. All nascent polypeptides must traverse and exit this tunnel, which extends 120 Å through the large (50S in bacteria) subunit from the peptidyl transferase center (PTC) to the subunit exterior; this encompasses 30-40 amino acids of the nascent chain during protein synthesis. Recent data have shown that interactions of the nascent chain with the exit tunnel can modulate the rate of protein synthesis, leading to pausing or stalling of translational elongation (Marin, 2008; Wilson and Beckmann, 2011) . Small-molecule ligands that bind within the exit tunnel can also induce stalling of translation elongation. Macrolide antibiotics, which include the representative drug erythromycin, bind in the exit tunnel near the PTC, contacting RNA (A2058 and A2059) and protein (L4 and L22) residues (Dunkle et al., 2010) . Traditionally, erythromycin and other macrolides have been considered to work as simple plugs in the NPET, blocking passage of the nascent peptide and inhibiting further peptide synthesis. This would eventually lead to peptidyl-tRNA drop-off from the ribosome that could deplete the cell of available tRNAs (Menninger and Otto, 1982) .
This simple mechanism is challenged by recent experiments that underscore the interactions of the nascent chain, tunnel, and macrolide in translational elongation. Translation in the presence of erythromycin of a short regulatory leader peptide, ErmCL, in the erythromycin resistance ermC cassette results in a stalled ribosome complex, with the peptidyl-tRNA stably bound. The stalled complex facilitates rearrangement of an immediate downstream mRNA secondary structure, opening up a normally hidden ribosome binding site on the downstream ermC methyltransferase gene, thus providing macrolide resistance to the cell (Weisblum, 1995) . This regulation requires a specific amino acid sequence in the ErmCL, suggesting sequence-specific interactions among the nascent peptide, ribosome, and drug (Vazquez-Laslop et al., 2008) .
The discovery of peptide sequences that are resistant to macrolides provides further evidence for sequence-specific interactions of the nascent chain with macrolides (Tenson and Mankin, 2001 ). Translation of a penta-peptide encoding open reading frame (ORF) inside the E. coli 23S rRNA causes low-level erythromycin resistance by a mechanism in which the short nascent peptide evicts the drug (Lovmar et al., 2006) ; the length and the specific amino acid identities of the short peptide are crucial for resistance efficiency.
Finally, although macrolides occupy space in the tunnel normally available to the nascent peptide, they do not occlude the tunnel completely (Bulkley et al., 2010; Dunkle et al., 2010; Schlü nzen et al., 2001; Tu et al., 2005) . Recently, Kannan et al. (2012) showed that certain peptide sequences can allow full translation by ribosomes that most likely retain erythromycin bound inside the NPET, with the nascent peptide passing by the drug during elongation.
Overall, these results suggest a complex interplay between the nascent peptide and the exit tunnel. How cofactordependent (e.g., ErmCL) or -independent (e.g., SecM; Wilson and Beckmann, 2011) stalling is mediated and whether specific interactions are needed between the NPET, peptide, and, if applicable, the drug molecule, to produce stalling remain unanswered questions. How these two general pathways for stalling compare remains unclear: recent single-molecule dynamics experiments have shown that SecM-induced stalling occurs gradually through a series of key nascent peptide-tunnel interactions, leading to a distribution of final stall sites , in this issue of Cell Reports). During elongation on macrolide-bound ribosomes, the outcome may depend not only on the macrolide structure (Kannan and Mankin, 2011) , but also on the specific amino acid sequence of the peptide being synthesized.
To delineate and distinguish these distinct mechanisms of macrolide sensitivity and resistance, we applied single-molecule fluorescence to observe translation directly in real time. Our results reveal distinct compositional and conformational dynamics of the translating ribosome in the presence of macrolides, depending on the specific amino acid sequence of the nascent peptide. The dynamic pathways of nascent-chaindependent elongation pausing in the presence of macrolides determine the fate of the translating ribosome.
RESULTS
Intersubunit FRET Signal for Real-Time Tracking of Elongation Dynamics on ermCL To follow elongation dynamics directly, we used ribosomal intersubunit Fö rster resonance energy transfer (FRET) to track the ribosome movement in real time while it translates an mRNA. With the 30S and the 50S subunits site specifically labeled on helix 44 on 16S rRNA with a fluorescent donor dye (Cy3 or Cy3B) and helix 101 on 23S rRNA labeled with an acceptor dye (Cy5), FRET efficiency between the two dyes upon excitation of the donor depends on the rotation of the two subunits with respect to each other (Marshall et al., 2008) . During one elongation cycle, the two subunits start in a nonrotated state, to which the EF-Tu,GTP,aa-tRNA ternary complex (TC) binds to the vacant A site, EF-Tu-bound GTP is hydrolyzed and peptidyl transfer from P-site tRNA to the A-site aa-tRNA occurs. This nonrotated state results in high FRET between the two dyes ( Figure 1A ). After peptidyl transfer, the two subunits rotate 6$10 degrees relative to each other, resulting in a longer distance between the dyes and thus lower FRET efficiency. When translocation of the tRNAs and mRNA on the ribosome is completed through the action of EF-G, the two subunits rotate back to their original position-the high-FRET state-and the cycle is completed ( Figure 1A ). Assuming that practically all these FRET cycles are productive, i.e., an amino acid is incorporated, this signal allows us to track ribosome movement and substeps along the mRNA with codon resolution. The validity of this system was previously demonstrated on simple mRNA models containing a few different codons Tsai et al., 2013 ) that correspond to purified tRNAs. To follow elongation on natural heteropolymeric mRNAs, such as ermCL, we prepared a semipurified aaRS mixture to charge total E. coli tRNA. The complete set of aa-tRNAs was then purified and used together with the intersubunit FRET signal to allow real-time tracking of elongation dynamics on any mRNA sequence.
To probe the translation elongation dynamics on ermCL mRNA, we employed single-molecule analysis of intersubunit FRET during translation. We delivered a mixture of EF-G, a set of total aa-tRNA,GTP,EF-Tu TCs along with 50S subunits labeled with a fluorescence quencher (black-hole quencher [BHQ]; Chen et al., 2012) to preinitiation [Cy3B]30S complexes (PICs, consisting of mRNA, fMet-tRNA fMet , IF2-GTP, and 30S subunits), formed on ermCL mRNA immobilized on a microscope slide ( Figure 1B ). The fluorescence intensity of individual [Cy3B]30S subunits were recorded over time, and individual time traces were subsequently analyzed ( Figure 1C ). The use of BHQ rather than the traditional Cy5 as FRET acceptor allows the use of Cy5 to label other reagents, such as tRNA or protein factors , and extends the observation window for ribosome dynamics to the lifetime of the longer-lived Cy3B dye (up to several minutes). The latter was necessary when tracking the elongation dynamics through pausing and stalling events. As can be seen in the survival plot ( Figure 1D ), where the percentage of elongating ribosomes at each codon is shown, a good proportion (>20%) of ribosomes translate the whole ermCL message within the Cy3B lifetime. With subsaturating concentrations of TCs and EF-G, the lifetimes of the nonrotated state (high-FRET) and the rotated state (low-FRET) are inversely proportional to the TC and EF-G concentrations, respectively. At 1.5 mM total aa-tRNA, nonrotated lifetimes are around 10 s ( Figure 1E) ; thus, an effective association rate constant of roughly 2 mM À1 s À1 can be estimated from the relative abundances of tRNA reading the ermCL message (Dong et al., 1996) . This is in agreement with previously estimated TC association rates to immobilized ribosomes and hence suggests that the total aa-tRNA preparation is functional. The nonrotated and rotated state lifetimes are fairly constant throughout the whole message (Figure 1E ). The slightly higher lifetimes of the nonrotated state at later codons might be due to relatively lower abundance of several of the respective tRNA isoacceptors in the E. coliextracted total tRNA (e.g., tRNA
Pro3
), the tRNAs corresponding to the last six codons being on average 1.8-fold lower in concentration in E. coli cells (Dong et al., 1996) than the ones reading the first 12. The waiting times in the rotated state are constant throughout the mRNA, consistent with constant EF-G concentration during the experiment and suggesting no significant energetic barriers to translocation at a specific codon.
Erythromycin Induced Ribosome Stalling on ermCL
The presence of saturating concentrations of erythromycin (1 mM) drastically changes the translation dynamics of ermCL ( Figure 2A ). The survival plot ( Figure 2B ) shows a clear inhibition of translation elongation, with an abrupt halt around the (B) Tracking of single elongating ribosomes was done using a TIRF microscope set-up with mRNA-immobilized 30S PICs onto which a mixture of EF-G, a set of total aa-tRNA,GTP,EF-Tu ternary complexes along with 50S subunits was delivered. (C) The dynamics of ermCL translation was followed in real time using intersubunit FRET between Cy3B and BHQ. Transition from low Cy3B intensity (high FRET) to high intensity (low FRET) and back to low intensity again reports on one elongation cycle, i.e., peptidyl transfer and subsequent translocation. When the ermCL mRNA is completely translated, the ribosome stops in a nonrotated (low Cy3B intensity) state with the stop codon in A site. previously suggested stall site (27% of ribosomes stop specifically at Ser10 codon in A site) (Vazquez-Laslop et al., 2008) ; no ribosome proceeds beyond the Val12 codon. Elongation kinetics in the presence of erythromycin is not disrupted during the rotated state at any codons ( Figure S1A ) but is increased in the nonrotated state at the stall site and beyond ( Figure 2B ). When the concentration of erythromycin was halved (0.5 mM), the same stalling pattern and elongation dynamics were seen ( Figure S1B ). Because the average lifetimes are calculated only from processive events (to exclude, e.g., abnormal dye behavior), the lifetime of the nonrotated state at codon Ser10, as reported in Figure 2B , does not include the long stalling times as shown in the trace in Figure 2A . The same analysis, but including the lifetime after the final state transition, results in the same trend ( Figure S1C ). Ninety-seven percent of the ribosomes reading to or beyond codon Ile9 in A site end in the nonrotated state. This is consistent with previous results suggesting that ribosomes stall after translocation to the Ser10 codon and are incapable of catalyzing peptidyl transfer from tRNA Ile in P site to the following Ser-tRNA Ser (Vazquez-Laslop et al., 2008) .
To compare erythromycin inhibition of ermCL translation to that of a generic mRNA, we performed the same experiments using the phage T4 gp32 mRNA. In absence of erythromycin, translation occurs normally across more than 30 codons with lifetimes for the nonrotated and rotated states as expected from TC and EF-G concentrations . The presence of erythromycin results in earlier elongation termination, with no particular end state favorable ( Figure 2C ). The lifetimes of the rotated ( Figure 2C ) and nonrotated ( Figure S1E ) states are similar to the lifetimes on ermCL, with or without drug, but lack the long-lived nonrotated state at the stall site of ermCL with drug. Hence, the only clear signature of drug binding on this generic mRNA is the early termination events, whereas elongation kinetics on these early codons is not significantly affected.
Peptide Sequence-Dependent ermCL Stalling We next tested the effects of nascent chain mutations on ermCL stalling. Prior biochemical experiments underscored the importance of amino acids 6-9, whose mutation to Ala abolished stalling at the Ser10 codon, whereas the identity of the first codons, or the Ser10 codon, was shown not to be important (Vazquez-Laslop et al., 2008) . We performed dynamic translation elongation experiments on an ermCL mutant where the Ile9 codon was changed to alanine (ermCL(I9A)); no effect of the mutation was observed in the absence of erythromycin, whereas in the presence of drug there was a decrease in ribosomes stalled at codon 10 in the A site compared to wildtype stalling (31% reaching codon Thr11, compared to 18% for the wild-type sequence) ( Figure S1D ). There was a long pause in the nonrotated state with codon 10 in the A site, although this pause was shortened compared to wild-type and allowed a larger fraction of ribosomes to continue elongating. The relatively high lifetimes of the nonrotated state on codons downstream of the stall site suggest that the drug is still bound and compromises elongation dynamics subsequent to codon 10.
One power of single-molecule experimentation is parsing distinct pathways. To distinguish whether ribosomes that stall or read through the stall site follow distinct mechanisms, we parsed the individual time traces from the experiment with the I9A mutant depending on whether the ribosomes pass the stalling site or not. This analysis indicated no difference in elongation kinetics on early codons ( Figure S1F ). There is no statistically distinct event occurring before the ribosome reaches the stall site that determines whether stalling occurs; thus, stalling of ribosomes at codon 10 of ermCL(I9A) in presence of erythromycin is stochastic.
Other mutations to the nascent chain within the critical sequence gave similar results as ermCL(I9A) ( Figure S1G ). Mutations of codon Ile6 (ermCL(I6A)) also showed reduced stalling, as with ermCL(I9A), whereas changes of codon Ser10 ermCL(S10A) had no effect on erythromycin-induced stalling, giving results similar to wild-type ermCL. An ermCL(S5A) mutant displays behavior intermediate to that of the wild-type/S10A and the I6A/I9A mutants ( Figure S1G ). Thus, elongation was inhibited by erythromycin on all of the ermCL variants tested, but only the wild-type sequence and the S10A mutant displayed a clear preference for elongation halt at codon Ser10. Elongation on all ermCL variants results in longer-than-normal lifetimes of the nonrotated state around the stall site and little or no effect on the lifetimes of the rotated state. The overall reading length on the ermCL mRNAs were in all cases longer than on the gp32 mRNA where elongation terminates preferentially around codons 4-6. Thus, the ErmCL sequence allows translation of a longer peptide (nine amino acids) than a random mRNA sequence in the presence of erythromycin.
Translation inhibition by erythromycin on wild-type and mutant ermCL was confirmed in a bulk assay probing for the timedependent production of full-length ErmCL peptides using 3 H-labeled Lys (Supplemental Experimental Procedures). In presence of erythromycin, the concentration of full-length ErmCL peptide was 20% or less than in the control experiments performed in absence of drug for all the sequence variants described above ( Figure S1H ).
To determine whether the pause in elongation of ErmCL is limited by TC binding, we measured elongation dynamics on ermCL in the presence of erythromycin at 2-fold higher TC concentration; the lifetimes of the nonrotated state on the first few codons decreased roughly 2-fold on both ermCL wild-type and I9A mutant ( Figure S1I ). This indicates TC-association-limited elongation kinetics and thus further shows that the elongation dynamics on these first codons are not disrupted by drug presence. However, the lifetimes of long-lived pauses/stalls from codon nine and onward were not affected by TC concentration, demonstrating that the drug abruptly perturbs ribosome function when a sufficiently long peptide has been synthesized. In the absence of drug, the lifetimes of the nonrotated state over all codons were on average decreased 2-fold (2.0 ± 0.2, Figure S1I ) at 2-fold higher TC concentration, as would also be expected from TC association rate-limited elongation kinetics.
The ermCL-Stalled Complex Has a Perturbed aa-tRNA Selective PTC To characterize the stalling site further, we investigated tRNA dynamics on codon Ser10. As the tRNA Ser isoacceptor reading the wild-type AGC Ser10 codon is not readily labeled using our approaches (Blanchard et al., 2004) , we used an ermCL mRNA with the nonessential Ser10 codon ( Figure S1G ; Vazquez-Laslop et al., 2008) mutated to Lys (ermCL(S10K)), which should yield a stalled complex with a Lys codon displayed in A site. The conformational and compositional state of the ribosome during the stall was probed by correlating binding of Cy5-labeled tRNA Lys with the Cy3B/BHQ intersubunit FRET signal. To produce a TC mix with the unlabeled wild-type tRNA Lys exchanged for [Cy5] tRNA Lys , we charged and purified total tRNA while leaving out the Lys amino acid. The purified DLys aa-tRNA mixture has 5% or lower concentration of Lys-tRNA Lys compared to our purified total aa-tRNA preparation, as judged from the differences in lifetimes of the nonrotated state when a model mRNA, consisting of six Phe-Lys repeats (6(FK) mRNA), is translated on the TIRF microscope slide with normal or DLys aa-tRNA-containing delivery mixes ( Figure S2A Figure 3A ). The majority of the Cy5-tRNA Lys binding events (62%) occurred as predicted at the Lys10, Lys18, and Lys19 codons ( Figure 3B ), with some background of spurious events due to tRNA sampling. When erythromycin was included in the delivery mix the [Cy5]tRNA Lys binding events on Lys18, Lys19 disappeared. In addition, the Cy5-tRNA Lys binding events on the Lys10 codon also disappeared almost completely ( Figure 3B ), suggesting that, although the A site Cell Reports 7, 1-13, June 12, 2014 ª2014 The Authors 5 contains the Lys10 codon, the ribosome is not capable of stably binding and accommodating Lys-tRNA Lys .
Other peptide sequences (e.g., ErmAL1 [Ramu et al., 2011] Figure 3C ). Thus, accessibility and stability of the A-site-tRNA interactions for macrolide-stalled ribosomes on ermCL depends on the sequence of the stall site itself. The stalled ribosome has completed translocation of the Ile9 codon to the P site, but the [Cy5]tRNA Lys and [Cy5] tRNA Phe experiments suggest that this back-rotated ribosome conformation is perturbed in A-site aa-tRNA binding and/or accommodation. One possibility could be that the peptidyl-tRNA, now reaching far into the drug-obstructed tunnel, is prevented from proper translocation into the P site, and hence that intersubunit rotation and mRNA/tRNA movements are decoupled. To monitor translocation directly, we tracked deacylated tRNA Val occupancy at the Val8 codon, which during proper translocation should dissociate rapidly once positioned in the ribosomal E site (Uemura et al., 2010) . When Cy3-labeled Val-tRNA Val was delivered together with a DVal aa-tRNA mix and [Cy5]50S subunits to immobilized [Cy3.5]30S PICs ( Figure 4A ), the lifetimes of the Cy3 pulses, representing the time the tRNA Val stays bound to the ribosomes, were the same in presence and absence of erythromycin (7.5 ± 0.7 and 7.1 ± 0.5 s, respectively, Figure 4B ). This result shows rapid eviction of tRNA Val when the ribosome reaches the stall site, and thus suggests translocation of the mRNA and tRNA molecules on the ribosome. The time to translate the message up to the first [Cy3]tRNA Val signal (Val8) was the same with or without drug (107 ± 10 and 100 ± 7 s, respectively), and the time between the arrival of the first and second [Cy3] tRNA Val in absence of drug was 62 ± 8 s ( Figure 4C ). These values agree with translation rates derived from individual codon lifetimes using the intersubunit FRET signal ( Figure 1E ).
Translation of the h-ns Readthrough mRNA Involves a Pause in the Rotated State The sequence of the nascent chain determines its sensitivity to erythromycin (Kannan et al., 2012) . Peptide sequences that are resistant to macrolide action may allow the peptide to sneak past the tunnel-bound macrolide. To investigate readthrough in the presence of macrolides, we prepared an mRNA consisting of the first 12 codons of the h-ns ORF, which is sufficient to Figure S2 .
rescue full-length protein synthesis when fused N-terminally to other genes (Kannan et al., 2012) , followed by a Lys-Phe-STOP sequence ( Figure 5A ). A Cy3B/BHQ intersubunit FRET experiment in the presence of erythromycin shows that readthrough of erythromycin-induced termination can occur: a large fraction (18%) of ribosomes reach the stop codon ( Figure 5B ). In contrast to the experiments with the ermCL variant mRNAs in the presence of macrolide, the lifetimes of the nonrotated state are fairly constant and low throughout the whole message. Instead, translation of h-ns in the presence of erythromycin shows prolonged lifetimes of the rotated state, in particular during translocation between Leu8 and Asn9 in A site ( Figures 5A, 5B , and S3A). Low-level readthrough of h-ns in the presence of erythromycin was confirmed in the bulk translation assay similar to what was done for the ermCL variants. For h-ns the incorporation of [ 3 H]Phe into peptides was used to monitor full-length peptide synthesis ( Figure S3B) , yielding approximately 40% full-length product in presence of the drug compared to the control experiment performed in absence of drug.
To characterize the elongation dynamics of h-ns readthrough in the presence of macrolides, we used Cy3B/BHQ intersubunit FRET correlated to the arrival of Phe-[Cy5]tRNA Phe .
Because a unique Phe codon was inserted adjacent to the stop codon, colocalized Cy3B and Cy5 fluorescence indicates ribosomes that have translated past the potential pause site ( Figure 5C ). ure 5D). The lifetimes of the nonrotated state are fairly constant throughout the message and do not differ significantly from the times obtained when the same experiment is performed in absence of drug. The lifetimes of the rotated state in the presence of the drug are the same as in the absence of drug except with the Leu8 in A site, where the lifetime is extended significantly (19 ± 4 s compared to 4.8 ± 1.4 s in absence of drug, or 6.2 ± 0.7 s on average on the other codons). After this pause, the ribosome continues elongating the H-NS peptide with no obvious perturbation. Interestingly, the other Leu codon, at position 5, shows a prolonged lifetime, although to a lesser extent (10 ± 2 s). Increasing the concentration of erythromycin 4-fold (4 mM) or decreasing it 2-fold (0.5 mM) did not change the H-NS elongation dynamics significantly ( Figure S3C ).
As with ErmCL stalling, the long pause in the rotated state at codon 8 of h-ns mRNA in the presence of erythromycin is not changed by increased factor concentrations. We repeated the Cy3B/BHQ intersubunit FRET experiment on h-ns using Phe-[Cy5]tRNA Phe in presence and absence of erythromycin, now with 8-fold higher TC concentration (12 mM DPhe aa-tRNA) and 4-fold higher EF-G concentration (640 nM). In the absence of drug, as expected, the lifetimes of the nonrotated state decreased proportionally (9.5 ± 0.9 to 1.5 ± 0.3 s on average) except on the first codon where the dissociation of IF2 after subunit joining takes approximately 2 s irrespective of TC concentration (Figure S3D ). The lifetimes of the rotated state did not completely scale with concentration (4.2 ± 0.4 s at low to 2.2 ± 0.2 s at high concentrations on average) suggesting a maximal translocation rate of 0.75 s À1 under these experimental conditions. Comparing the overall time from subunit joining to the Cy5 signal (representing the time to read 11
Cell Reports 7, 1-13, June 12, 2014 ª2014 The Authors 7 codons) between experiments at high ( Figure S3E ) and low factor ( Figure 5C ) concentrations and in the presence or absence of drug, it is apparent that the slow translation of h-ns in the presence of erythromycin is not rescued by higher factor concentrations ( Figure S3F ). To investigate whether the pause in the rotated state on h-ns is a general feature linked to elongation through an erythromycin-obstructed tunnel, we translated another mRNA N-terminal sequence reported to rescue translation of erythromycin sensitive sequences, the first 18 codons of hspQ (Kannan et al., 2012) . In the presence of 1 mM erythromycin, no full-length synthesis was observed ( Figure S3G ). However, a very long pause in the rotated state at codon Ile8 resembles the similar pause at the Leu8 codon in h-ns. Thus elongation of the HspQ N-terminal sequence also clearly displays the same kinetic signature as achieved with h-ns translation in presence of erythromycin. 
EF-G Does Not Efficiently Resolve the Rotated-State Pause at Leu8 in h-ns
We calculated Cy3B-Cy5 FRET values on each individual codon when repeating the h-ns intersubunit FRET experiment in the presence of erythromycin using Cy5-rather than BHQ-labeled 50S subunits ( Figure 6A) . Averaging over the first five codons, the low-and high-FRET values fit very well to single Gaussian distributions with averages of 0.36 and 0.5, respectively. The stalled state is well described by the low-FRET state, with some mixing of high-FRET, perhaps due to short-lived transitions to the nonrotated state ( Figure 6B) .
By using Cy5-labeled EF-G in conjunction with the Cy3B/BHQ intersubunit FRET signal, we can track the ribosome intersubunit rotations as the ribosome moves stepwise on the mRNA and, simultaneously, observe the Cy5 pulses as EF-G engages the ribosome, catalyzing translocation, resulting in back-rotation of the subunits and a low-to-high Cy3B/BHQ-FRET transition (Figure 6C) . With this methodology, we can determine the time EF-G spends bound to the ribosome, and number of binding events, on each codon . To allow detection of labeled EF-G binding events at high factor concentrations, the experiment was conducted in zero-mode waveguides (ZMWs) rather than on the TIRF set-up, because ZMWs allow much higher dye-labeled ligand concentrations in the solution Uemura et al., 2010) . Hence, h-ns [Cy3B]30S-PICs were immobilized on a chip of ZMWs onto which a mixture of total TCs, [BHQ]50S, and [Cy5]EF-G was delivered ( Figure S4A ). The number of EF-G binding events per translocation ( Figure 6D ) was approximately one on most codons, as observed previously , but an increased number of binding events was observed during the long pause at Leu8 (3.0 ± 0.4 binding events on average). The average time EF-G spent bound to the ribosome was the same on all codons ($200 ms), and the dwell times on codon Leu8 was, as during normal translocation , best fitted to a three step model ( Figure S4B ). Thus, EF-G binds normally to the long-lived rotated pause state at codon Leu8 of the h-ns mRNA, but on average three EF-G binding attempts that probably involve GTP hydrolysis are needed before translocation and back-rotation of the subunits occurs successfully.
DISCUSSION
Despite decades of research and clinical use, a detailed mechanistic explanation for the bacteriostatic effects of macrolides is lacking. High-resolution crystal structures of the ribosomal nascent peptide exit tunnel and complexes with macrolides (Bulkley et al., 2010; Dunkle et al., 2010; Schlü nzen et al., 2001; Tu et al., 2005) suggested that the traditional model for macrolide action involving full steric blocking of the exit tunnel is likely incorrect, because there is enough space between the drug and the tunnel wall for peptides to pass by. The recent observations of ribosome stalling or readthrough in the presence of macrolides strongly suggest a complex interplay of drug, nascent-peptide chain, and ribosome during translation (Kannan et al., 2012) . To gain insight into the determinants of these stochastic, highly dynamical processes, we used fluorescence-based assays developed in our group for real-time tracking of single translating ribosomes. The system has been used extensively to track various aspects of protein synthesis (e.g., Tsai et al., 2012; Uemura et al., 2010) , including elongation dynamics during SecM stalling . In the present study, we applied this system to unravel the mechanisms of inhibition by macrolides during translation of several different mRNAs.
We first reproduced the features of ribosome stalling on the well-studied short leader ORF in the ermC cassette, ermCL. In absence of drug, the 19 codon ermCL message is translated to the stop codon with a relatively constant rate ( Figures 1C  and 1E ). In the presence of erythromycin, our single-molecule measurements on ermCL agree with results from ensemble experiments-elongation is severely inhibited and a relatively large fraction of the ribosomes stop specifically at the previously proposed stalling site, with the Ser10 codon in A site. The stall occurs in a nonrotated state, also consistent with the observation Cell Reports 7, 1-13, June 12, 2014 ª2014 The Authors 9 that the stalled ribosomes are not capable of catalyzing peptidyl transfer to Ser-tRNA Ser (Vazquez-Laslop et al., 2008) . The small fraction of ribosomes reaching beyond the stall site (7% reaching codon Val12) implies that stalling is not complete but could also be explained by codon-to-codon uncertainty in assignments and/or the possibility that the drug molecule dissociates.
The observations of stalling observed in our system are independent of translation rate. In our experimental set-up, the lifetimes of the nonrotated and rotated states during normal elongation represent mainly the waiting times for TC and EF-G to arrive, respectively. The factor concentrations were tuned to balance on one hand the need to translate fast enough to see full-length synthesis during the photobleaching limited dye lifetime, and on the other hand slow enough for us to be able to separate individual state transitions. We have addressed the potential problems due to this discrepancy with in vivo elongation rates (0.07-0.3 s À1 in our assays versus $5 s À1 at 20 C in vivo) (Ryals et al., 1982) by showing that elevated factor concentrations do not affect the pausing/stalling events investigated.
Comparing the results achieved with ermCL to the results from a more general mRNA, gp32, the ErmCL N terminus allows elongation of a longer nascent peptide (46% and 13% reaching codon 10 on ermCL and gp32, respectively) in presence of erythromycin. The lifetimes of the nonrotated and rotated state are fairly similar between the two mRNAs except for the long pause/stall at codon Ser10 on ermCL. Whereas the stall on ermCL occurs in the nonrotated state, the end state on gp32 seems to be equally distributed between rotated and nonrotated. Inhibition of peptide elongation by macrolides causes peptidyl-tRNA drop-off (Menninger and Otto, 1982) . In our present analysis, we cannot tell if or when peptidyl-tRNA dissociates from the ribosome. However, similar lifetimes of the nonrotated state on early codons in elongation of ErmCL and GP32 in the presence of erythromycin on one hand, and ErmCL in the presence or absence of the drug on the other hand, both suggest that increased peptidyl-tRNA drop-off would not be caused by prolonged waiting times. Rather, the tunnel-bound drug might prevent stabilizing contacts between the peptide and the tunnel wall, accelerating peptidyl-tRNA drop-off in a peptide sequencedependent manner. The fact that no stalling was seen on erm-CL(I9A) in prior toe-print assays (Vazquez-Laslop et al., 2008) , although elongation is still terminated prematurely ( Figure S1D ), suggests that this minor change to the peptide sequence results in an elongation halt, now due to peptidyl-tRNA drop-off rather than the formation of a stable stalled complex.
Our results underscore the dynamic nature of the drugnascent chain-tunnel interaction. Incorporation of the first seven to eight amino acids on ermCL are not kinetically altered by the presence of erythromycin, despite the fact that the growing peptide should have already encountered the tunnel-bound drug molecule after a tri-or tetrapeptide has been synthesized (Tu et al., 2005) . Unhindered elongation of these first eight amino acids in the presence of drug is additionally supported by the decrease in lifetimes of the nonrotated state with higher TC concentration, at least up to codon Val8, and similar dwell times of [Cy5]tRNA
Val in presence or absence of erythromycin. Ribosomes in the presence of macrolide can thus translate up to codon 10 in the A site with normal elongation rates, limited in our experiments by TC and EF-G concentrations. Upon reaching the codon Ser10, further elongation is blocked. Macrolidemediated stalling of elongation is abrupt, in contrast to the gradual slowdown and heterogeneous stall positions observed in SecM-mediated stalling .
Our results agree with prior biochemical experiments that clearly showed ribosomes translating ermCL stalled with codon Ser10 in the A site, but before peptidyl transfer to a Ser-tRNA Ser (Vazquez-Laslop et al., 2008 with these trends, Phe and Lys were the least and most stalling efficient A-site codons, respectively, on the ermAL1 stalling ORF (Ramu et al., 2011) . Whereas ermCL(S10F) elongation is still efficiently terminated ( Figure S2B ), this observation suggests that the ermCL-stalled complex also has a selective A site, similar to the ermAL1-stalled complex, and that the selectivity lies in accommodation of the aa-tRNA rather than in the peptidyl transfer reaction. This possibility was previously broached (Ramu et al., 2011) , regarding amino acid dependence in aatRNA accommodation pathways (Whitford et al., 2010) . Results from the characterization of ermAL1 stalling together with our findings would thus suggest that amino acids with hydrophobic side chains accommodate more easily into or are stabilized at the PTC. The ermCL wild-type Ser10 codon has an intermediate stalling efficiency on ermAL1 and would likely have intermediate A-site accommodation efficiency on ermCL. Elongation of the H-NS readthrough peptide showed a unique dynamic signature in the presence of erythromycin. As with ermCL, there is a long-lived pause during elongation in the presence of macrolide, but now in the rotated ribosomal state after incorporation of Leu8. After approximately three translocation attempts by EF-G, the ribosome is reset and translocates and then continues translating the message with no inhibition of subsequent elongation steps, i.e., as with no drug bound. Because EF-G binds normally to the paused h-ns complex (with normal dwell time and time distribution, but with an elevated number of binding events required), it is likely that the A-site peptidyl-tRNA is moved properly into the hybrid state subsequent to peptidyl transfer. However, the pause time is not dependent on EF-G concentration (the difference between the overall elongation times in presence and absence of drug did not decrease at high factor concentration). This suggests a significant translocation barrier and suggests that movement of the peptidyl-tRNA from A site to P site during translocation involves movement of the nascent peptide inside the tunnel, and that these peptide movements are hindered by the tunnelbound drug.
Our results lead to a model for readthrough of ribosomes during synthesis of specific nascent peptides in the presence of macrolides. After synthesis of an octapeptide (H-NS), translocation is blocked, but specific interactions among the nascent peptide, drug, and tunnel stabilizes peptidyl-tRNA long enough for structural rearrangements to occur so that elongation can resume. The most straightforward hypothesis would be that the paused state is resolved by erythromycin dissociation. However, increasing the concentration of erythromycin 4-fold, which would potentially make reassociation of the drug four times faster, did not alter the pause time. Moreover, in Kannan et al. (2012) it was cleverly shown, by fusing ermCL 3 0 to h-ns, that, despite readthrough on h-ns, the ribosome would still stall on the 3 0 fused ermCL, suggesting that erythromycin is still bound inside the tunnel. Although the drug molecule could be first evicted and then rebind at a later stage, these observations strongly suggest that the H-NS peptide is capable of bypassing the tunnel-bound drug (Kannan et al., 2012) . In the macrolidebound ribosomes, the space available for the peptide to pass through the tunnel is limited by the drug and the highly flexible nucleotide A2062 (Fulle and Gohlke, 2009 ). Thus, the observed pause could be due to a reorganization within the tunnel, e.g., moving the A2062 base toward the tunnel wall (Kannan et al., 2012) , allowing complete movement of the peptidyl-tRNA to the P site, subsequent back-rotation of the subunits and further peptide elongation.
In conclusion, our results show how elongation dynamics for a macrolide-obstructed NPET are modified by the sequence of the nascent peptide (Figure 7 ). Peptide elongation rates are not severely inhibited in general by the presence of the macrolide inside the NPET, but stalls (ermCL) or pauses (h-ns) are abrupt, sequence-specific events. The cause of increased peptidyltRNA drop-off in the presence of the macrolide (Tenson et al., 2003 ) is likely not due to increased waiting time. Rather, the drug may disrupt necessary stabilizing contacts between the nascent peptide and the tunnel resulting in higher probability of elongation abortion due to peptidyl-tRNA drop-off. Certain peptides, such as ErmCL, H-NS, or HspQ, might be sufficiently stable in presence of bound macrolide and hence can bypass the drug with a higher probability than a general peptide, such as GP32. Whereas elongation of the stall peptides eventually leads to perturbation of the A site preventing proper alignment of the aa-tRNA into the PTC, the readthrough peptides likely cause rearrangements within the tunnel that allow continuation of elongation after the pause. Further structural and dynamics experiments will be needed to correlate drug occupancy with nascent peptide interactions and elongation dynamics.
Our results underscore the power of single-molecule methods to provide real-time monitoring of complex biological processes. The ability to track single elongating ribosomes in real time on complex mRNAs will permit further investigations of how elongation rates are regulated during translation by mRNA and nascent protein sequence, folding, and structure.
EXPERIMENTAL PROCEDURES

Reagents and Buffers
Fluorescently labeled, or wild-type ribosomal subunits, IF2, ribosomal protein S1, fluorescently labeled tRNAs, and unlabeled fMet-tRNA fMet were prepared as previously described (Blanchard et al., 2004; Dorywalska et al., 2005; Marshall et al., 2008) . Biotinylated mRNAs were either purchased (6(FK) from Dharmacon) or prepared by hybridizing the 5 0 UTR of in-house transcribed and purified mRNAs (for gp32: [McKenna et al., 2007] , all others: [Johansson et al., 2012] ) to a biotinylated DNA splint oligo (see Supplemental Experimental Procedures for sequences). A semipurified mix of aminoacyltRNA synthetases was prepared from E. coli S30 extract according to (Pavlov and Ehrenberg, 1996) . Total or D(Lys, Val or Phe) aa-tRNAs were prepared by incubating total E. coli tRNA (Sigma) with all amino acids (minus Lys, Val, or Phe for D mixes) together with the crude aaRS mix for 30 min at 37 C in a buffer Although the rate of peptide elongation is not affected by the presence of erythromycin in the NPET, stabilizing contacts between the nascent peptide and the tunnel are disrupted resulting in accelerated peptidyl-tRNA drop-off on early codons. Certain peptides can proceed with higher probability but interactions with the drug and the tunnel eventually lead to a halt in translation. Whereas stalling peptides induce a blockage of the PTC resulting in a stable stalled complex, readthrough peptides stabilize peptidyl-tRNA in the rotated state of the ribosome long enough for structural rearrangements within the tunnel to occur allowing resumed translation.
consisting of Tris-HCl (50 mM [pH 7.5]), KCl (50 mM), MgCl 2 (10 mN), and b-ME (3 mM), complemented with ATP (2 mM), phosphoenol pyruvate (PEP, 10 mM), pyruvate kinase (PK, 50 mg/ml), myokinase (MK, 2 mg/ml), and inorganic pyrophosphatase (PP i ase, 10 mg/ml). aa-tRNAs were thereafter purified by phenol extraction, ethanol precipitation, and gel filtration (Bio-Gel P-6 column, Bio-Rad) and finally stored in small aliquots at À80 C. All experiments were conducted at room temperature in a Tris-based polymix buffer consisting of 50 mM Tris-OAc (pH 7.5), 100 mM KCl, 5 mM NH 4 OAc, 0.5 mM CaOAc, 5 mM MgOAc, 0.5 mM EDTA, 5 mM putrescine, and 1 mM spermidine.
Single-Molecule Experiments on TIRF Microscope
Dye labeling of ribosomal subunits were always performed immediately before the experiments according to (Marshall et al., 2008) .
[Cy3B]30S PICs were formed by preincubating (5 min at 37 C) the labeled subunit (0.25 mM) with S1 (0.25 mM), IF2 (1 mM), fMet-tRNA fMet (1 mM), and 5 0 biotinylated mRNA (1 mM) in polymix buffer supplemented with GTP (4 mM). The PICs were diluted (20-to 200-fold) in polymix buffer containing IF2 (1 mM) and GTP (4 mM) and immobilized on the surface of a biotin-PEG derivatized quartz slide via biotin-neutravidin interactions. Excess unbound material was washed away with polymix supplemented with IF2 (1 mM), GTP (4 mM), and an oxygen scavenging system consisting of Trolox (1 mM), 3,4-dihydroxybenzoic acid (2.5 mM), and protocatechuate deoxygenase (250 nM). Total or D(aa) aa-tRNA,EF-Tu,GTP ternary complexes were preformed by incubating briefly (2 min at 37 C) the aa-tRNAs with 5-fold excess of EF-Tu, GTP (1 mM), PEP (3 mM), and EF-Ts (40 mM) in polymix. The TCs (final concentration in reaction 1.5-12 mM) were added to dye-labeled 50S (typically 100 nM), EF-G (80-640 nM), IF2 (1 mM), GTP (4 mM), erythromycin (1 mM, when applicable), and the oxygen scavenging system to form a delivery mix in polymix buffer. To initiate translation elongation on the immobilized PICs, the delivery mix was added to the quarts slide through a computer controlled syringe pump. The instrumental set-up consisted of a prism-based total internal reflection fluorescence microscope as previously described . For excitation of Cy3B, a diode-pumped solid-state 532 nm laser at 1 kW cm À2 was used, and for Cy5, when applicable, a 647 nm laser at 400 W cm À2 was used. Videos were recorded (typically at 10 fps with a total of 3,600 frames collected) using the MetaMorph software package (Molecular Devices) and fluorescent traces were extracted using in-house MATLAB (MathWorks) scripts. Intersubunit FRET states and Cy5 ligand (tRNA Lys , tRNA Phe ) binding events were assigned manually from productive traces showing stable [Cy3B]30S immobilization, joining of 50S (yielding high-FRET), and the highlow-high-FRET cycle signaling intersubunit rotation. Average lifetimes for the intersubunit FRET states were calculated only from productive states (i.e., low-FRET states that was followed by a high-FRET state and vice versa) to eliminate artifacts from photophysical effects.
Single-Molecule Experiments on ZMWs
[Cy3B]-or [Cy3.5]30S PICs were prepared as described for the TIRF experiments and immobilized through biotin-neutravidin linkage on chips containing 75,000 individual ZMWs with an average diameter of 130 nm . The delivery mixes were prepared as described for the TIRF experiments except for the use of Cy5-labeled EF-G (160 nM) for the experiment shown in Figure 6C or tRNA Val with a DVal aa-tRNA mix for the experiment in Figure 4A . Cy3B, Cy3.5, and Cy5 fluorescence was detected using direct excitation with lasers at 532 and 632 nm and laser power of 0.48 mW/ mm 2 and 0.22 mW/mm 2 , respectively. Fluorescence intensity was recorded from all ZMWs during 6 min at 10 fps, and time traces were selected and analyzed from ZMW wells containing exactly one immobilized Cy3B or Cy3.5 molecule using a similar set of MATLAB scripts as was used for the TIRF experiments. 
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